No Data
No Data
GSK's Top Selling Vaccine Can Potentially Reduce Dementia Risk, Research Suggests
GSK Wins EU Backing for RSV Vaccine for Those Aged 50 – 59
GlaxoSmithKline Sell Rating Justified by Arexvy Underperformance and Reduced Revenue Projections
GSK Says Health Canada Approves Jemperli as Endometrial Cancer Treatment
GlaxoSmithKline (GSK) Receives a Buy From Jefferies
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
No Data